In the Zone: bioanalytical matrices – disruption and solutions

The COVID-19 pandemic has strained the biological matrix supply chain. An upsurge in demand driven by numerous COVID-19 therapeutic and vaccine development programs to combat the pandemic, along with logistical challenges sourcing and transporting matrix, has led to increased lead times for multiple matrices. However, there are several mitigation strategies to help alleviate the current strain on the matrix supply chain and help prepare for any future unexpected strains.

INFOGRAPHIC

Infographic: Overcoming the challenges within the bioanalytical matrices supply chain  – In this infographic, we explore the challenges faced within the biological matrix supply chain and how to utilize select mitigation strategies that could ease delays and future strains.

PODCAST

Mitigation strategies for the biological matrix supply chain: an interview with Mark O’Dell – In this podcast interview, Mark O’Dell, Associate Director of Global Operations, Immunochemistry at Labcorp (MA, USA), explores how the COVID-19 pandemic has impacted the biological matrices supply chain and the mitigation strategies that could be put in place to overcome these obstacles.

RESOURCES

COVID-19’s impact on bioanalytical labs

Aging of biological matrices and its effect on bioanalytical method performance

A review of electrogenerated chemiluminescent biosensors for assays in biological matrices

[Video by Andrew McKinnon]

In association with: